| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 225.56B | 201.26B | 213.03B | 186.27B | 172.99B | 173.86B |
| Gross Profit | 53.95B | 47.94B | 35.25B | 17.83B | 16.06B | 16.32B |
| EBITDA | 49.58B | 48.71B | 31.39B | 20.17B | 17.10B | 17.11B |
| Net Income | 23.99B | 19.81B | 13.53B | 8.25B | 6.07B | 5.11B |
Balance Sheet | ||||||
| Total Assets | 222.94B | 202.53B | 170.24B | 172.97B | 165.02B | 137.45B |
| Cash, Cash Equivalents and Short-Term Investments | 61.24B | 48.43B | 36.94B | 39.00B | 36.88B | 31.44B |
| Total Debt | 37.39B | 31.66B | 29.64B | 50.86B | 48.66B | 46.86B |
| Total Liabilities | 116.29B | 102.58B | 84.29B | 101.01B | 102.98B | 89.19B |
| Stockholders Equity | 88.57B | 82.47B | 71.02B | 59.54B | 51.70B | 39.85B |
Cash Flow | ||||||
| Free Cash Flow | 22.38B | 13.50B | 27.49B | 2.62B | 4.94B | 1.91B |
| Operating Cash Flow | 31.35B | 20.89B | 32.39B | 15.54B | 15.45B | 6.19B |
| Investing Cash Flow | -18.87B | -8.74B | -1.16B | -10.66B | -7.37B | -4.89B |
| Financing Cash Flow | 2.16B | -8.28B | -30.57B | -8.61B | -2.10B | 7.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$19.60B | 2.01 | 23.30% | 1.89% | 37.79% | 209.90% | |
72 Outperform | HK$452.85B | 9.80 | 26.48% | 1.45% | 8.77% | 60.69% | |
72 Outperform | HK$51.91B | 22.66 | 32.65% | 1.32% | 68.93% | 451.13% | |
66 Neutral | HK$138.39B | 9.10 | 1.10% | 2.80% | 0.98% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | HK$2.72B | 13.96 | -14.35% | ― | -51.79% | ― | |
38 Underperform | HK$48.01M | -0.39 | -177.54% | ― | -26.77% | -69.57% |